Shah Nikita

CIK 00017380611 companyBRIDGEWATER, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001738061

Recent Transactions

50 trades

Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Stock Option (Right to Buy)
2025-11-12−95,525→ 0 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Stock Option (Right to Buy)
2025-11-12−36,331→ 0 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-11-12$11.92/sh−131,856→ 146,403 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-11-12$2.75/sh+95,525→ 278,259 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-11-12$2.75/sh+36,331→ 182,734 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-08-25$9.50/sh−6,340→ 146,403 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-08-22$9.66/sh−114,492→ 152,743 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-08-14$9.29/sh−71,694→ 267,235 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-08-12$9.04/sh−50,000→ 338,929 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-05-16$7.58/sh−49,140→ 388,929 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-04+35,879→ 107,640 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-04+35,879→ 456,422 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-04$8.84/sh−18,353→ 438,069 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03+36,232→ 345,871 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03+45,872→ 373,210 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-03+94,178→ 94,178 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2025-03-03+188,356→ 188,356 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-03−36,232→ 36,232 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03$8.76/sh−23,464→ 349,746 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-03−45,872→ 91,743 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03+144,928→ 494,674 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03$8.76/sh−74,131→ 420,543 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2025-03-03−144,928→ 0 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03$8.76/sh−18,533→ 327,338 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-01−28,958→ 0 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-01+28,958→ 320,624 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-01$8.67/sh−10,985→ 309,639 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-08-14$7.75/sh−100,000→ 291,666 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2024-03-04+287,038→ 287,038 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-03-04+143,519→ 143,519 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-03+45,871→ 414,648 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-03$5.47/sh−18,153→ 368,777 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-03+36,232→ 386,930 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-03-03−45,871→ 137,615 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-03-03−36,232→ 72,464 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-03$5.47/sh−22,982→ 391,666 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-01$5.47/sh−15,181→ 350,698 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-01+28,957→ 365,879 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-03-01−28,957→ 28,958 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-02-27−35,620→ 0 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-02-27$5.71/sh−18,670→ 336,922 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-02-27+35,620→ 355,592 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2023-03-03+36,232→ 338,036 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2023-03-03+366,972→ 366,972 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2023-03-03+183,486→ 183,486 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2023-03-03−36,232→ 108,696 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2023-03-03$1.92/sh−18,064→ 319,972 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2023-03-01−28,958→ 57,915 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2023-03-01+28,958→ 317,359 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2023-03-01$2.09/sh−15,555→ 301,804 total

Companies

Amneal Pharmaceuticals, Inc.
Executive Vice President
$AMRX

Recent Filings

Address

C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BLVD.

BRIDGEWATER, NJ, 08807

View on SEC.gov